• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

ENMD-2076 Drug Record

  • Summary
  • Interactions
  • Claims
  • ENMD-2076 chembl:CHEMBL482968 Antineoplastic

    Alternate Names:

    ENMD 2076
    ENMD-2076

    Drug Info:

    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antineoplastic agent
    Drug Class Kinase Inhibitors
    (5 More Sources)

    Publications:

    Yee et al., 2016, A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia., Invest New Drugs
  • ENMD-2076   NPM1

    Interaction Score: 0.3

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Indication/Tumor Type acute myeloid leukemia
    Response Type sensitive
    Approval Status Phase I

    PMIDs:
    27406088


    Sources:
    JAX-CKB

  • ENMD-2076   AURKA

    Interaction Score: 0.29

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Novel drug target Novel Target
    Trial Name ENMD-2076
    Mechanism of Interaction Serine/threonine-protein kinase Aurora-A inhibitor

    PMIDs:
    None found


    Sources:
    ClearityFoundationClinicalTrial TdgClinicalTrial TTD TALC MyCancerGenome GuideToPharmacology ChemblInteractions

  • ENMD-2076   PTK2

    Interaction Score: 0.16

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Direct Interaction? True
    Endogenous Drug? False
    Specific Action of the Ligand Inhibition

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial GuideToPharmacology

  • ENMD-2076   FGFR3

    Interaction Score: 0.15

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Fibroblast growth factor receptor 3 inhibitor
    Direct Interaction yes
    Notes

    PMIDs:
    None found


    Sources:
    ClearityFoundationClinicalTrial TALC MyCancerGenome ChemblInteractions

  • ENMD-2076   FLT3

    Interaction Score: 0.14

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Novel drug target Established target
    Trial Name ENMD-2076
    Indication/Tumor Type acute myeloid leukemia

    PMIDs:
    27406088


    Sources:
    JAX-CKB TdgClinicalTrial TALC GuideToPharmacology ChemblInteractions

  • ENMD-2076   FGFR2

    Interaction Score: 0.09

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ENMD-2076
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    ClearityFoundationClinicalTrial TdgClinicalTrial

  • ENMD-2076   KDR

    Interaction Score: 0.08

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Notes
    Direct Interaction yes
    Mechanism of Interaction Vascular endothelial growth factor receptor 2 inhibitor

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial TALC MyCancerGenome GuideToPharmacology ChemblInteractions

  • ENMD-2076   CSF1R

    Interaction Score: 0.07

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Macrophage colony stimulating factor receptor inhibitor
    Trial Name ENMD-2076

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • ENMD-2076   FGFR4

    Interaction Score: 0.07

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    ClearityFoundationClinicalTrial

  • ENMD-2076   PDGFRA

    Interaction Score: 0.07

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? True

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial GuideToPharmacology

  • ENMD-2076   BLK

    Interaction Score: 0.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Novel Target
    Trial Name ENMD-2076

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • ENMD-2076   KIT

    Interaction Score: 0.06

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Stem cell growth factor receptor inhibitor
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial ChemblInteractions

  • ENMD-2076   FYN

    Interaction Score: 0.06

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ENMD-2076
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • ENMD-2076   FLT4

    Interaction Score: 0.05

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Novel drug target Established target
    Trial Name ENMD-2076

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial MyCancerGenome

  • ENMD-2076   FGFR1

    Interaction Score: 0.05

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ENMD-2076
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    ClearityFoundationClinicalTrial TdgClinicalTrial

  • ENMD-2076   SRC

    Interaction Score: 0.05

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False
    Direct Interaction? True

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial GuideToPharmacology

  • ENMD-2076   NTRK1

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name ENMD-2076

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • ENMD-2076   AURKB

    Interaction Score: 0.04

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Serine/threonine-protein kinase Aurora-B inhibitor
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions

  • ENMD-2076   LCK

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ENMD-2076
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • ENMD-2076   RET

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ENMD-2076
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • ENMD-2076   ABL1

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ENMD-2076
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • ENMD-2076   JAK2

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ENMD-2076
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • ENMD-2076   FLT1

    Interaction Score: 0.03

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:

    PMIDs:
    None found


    Sources:
    MyCancerGenome

  • ENMD-2076   YES1

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ENMD-2076
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • MyCancerGenome: ENMD-2076

    • Version: 20-Jun-2017

    Alternate Names:
    ENMD-2076 Development Name

    Drug Info:
    Drug Class Kinase Inhibitors

    Publications:

  • TdgClinicalTrial: ENMD-2076

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class Small molecule
    FDA Approval not approved

    Publications:

  • JAX-CKB: ENMD-2076

    • Version: 27-September-2017

    Alternate Names:

    Drug Info:

    Publications:
    Yee et al., 2016, A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia., Invest New Drugs

  • TALC: ENMD-2076

    • Version: 12-May-2016

    Alternate Names:
    ENMD-2076 Primary Drug Name
    ENMD-2076 Drug Synonym

    Drug Info:

    Publications:

  • GuideToPharmacology: 249565576

    • Version: 29-September-2020

    Alternate Names:
    ENMD-2076 GuideToPharmacology Ligand Name

    Drug Info:

    Publications:

  • TTD: ENMD-2076

    • Version: 2020.06.01

    Alternate Names:
    D0S7HM TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL482968

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ClearityFoundationClinicalTrial: ENMD-2076

    • Version: 15-June-2013

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL482968

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21